Cargando…

AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery

Autophagy, originally described as a mechanism for intracellular waste disposal and recovery, has been becoming a crucial biological process closely related to many types of human tumors, including breast cancer, osteosarcoma, glioma, etc., suggesting that intervention of autophagy is a promising th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jiahui, Wu, Lifeng, Hu, Gaoyong, Shi, Qiqi, Wang, Ruodi, Zhu, Lingjuan, Yu, Haiyang, Fu, Leilei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395961/
https://www.ncbi.nlm.nih.gov/pubmed/36016573
http://dx.doi.org/10.3389/fphar.2022.956501
_version_ 1784771820888522752
author Fu, Jiahui
Wu, Lifeng
Hu, Gaoyong
Shi, Qiqi
Wang, Ruodi
Zhu, Lingjuan
Yu, Haiyang
Fu, Leilei
author_facet Fu, Jiahui
Wu, Lifeng
Hu, Gaoyong
Shi, Qiqi
Wang, Ruodi
Zhu, Lingjuan
Yu, Haiyang
Fu, Leilei
author_sort Fu, Jiahui
collection PubMed
description Autophagy, originally described as a mechanism for intracellular waste disposal and recovery, has been becoming a crucial biological process closely related to many types of human tumors, including breast cancer, osteosarcoma, glioma, etc., suggesting that intervention of autophagy is a promising therapeutic strategy for cancer drug development. Therefore, a high-quality database is crucial for unraveling the complicated relationship between autophagy and human cancers, elucidating the crosstalk between the key autophagic pathways, and autophagic modulators with their remarkable antitumor activities. To achieve this goal, a comprehensive database of autophagic modulators (AMTDB) was developed. AMTDB focuses on 153 cancer types, 1,153 autophagic regulators, 860 targets, and 2,046 mechanisms/signaling pathways. In addition, a variety of classification methods, advanced retrieval, and target prediction functions are provided exclusively to cater to the different demands of users. Collectively, AMTDB is expected to serve as a powerful online resource to provide a new clue for the discovery of more candidate cancer drugs.
format Online
Article
Text
id pubmed-9395961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93959612022-08-24 AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery Fu, Jiahui Wu, Lifeng Hu, Gaoyong Shi, Qiqi Wang, Ruodi Zhu, Lingjuan Yu, Haiyang Fu, Leilei Front Pharmacol Pharmacology Autophagy, originally described as a mechanism for intracellular waste disposal and recovery, has been becoming a crucial biological process closely related to many types of human tumors, including breast cancer, osteosarcoma, glioma, etc., suggesting that intervention of autophagy is a promising therapeutic strategy for cancer drug development. Therefore, a high-quality database is crucial for unraveling the complicated relationship between autophagy and human cancers, elucidating the crosstalk between the key autophagic pathways, and autophagic modulators with their remarkable antitumor activities. To achieve this goal, a comprehensive database of autophagic modulators (AMTDB) was developed. AMTDB focuses on 153 cancer types, 1,153 autophagic regulators, 860 targets, and 2,046 mechanisms/signaling pathways. In addition, a variety of classification methods, advanced retrieval, and target prediction functions are provided exclusively to cater to the different demands of users. Collectively, AMTDB is expected to serve as a powerful online resource to provide a new clue for the discovery of more candidate cancer drugs. Frontiers Media S.A. 2022-08-09 /pmc/articles/PMC9395961/ /pubmed/36016573 http://dx.doi.org/10.3389/fphar.2022.956501 Text en Copyright © 2022 Fu, Wu, Hu, Shi, Wang, Zhu, Yu and Fu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fu, Jiahui
Wu, Lifeng
Hu, Gaoyong
Shi, Qiqi
Wang, Ruodi
Zhu, Lingjuan
Yu, Haiyang
Fu, Leilei
AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery
title AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery
title_full AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery
title_fullStr AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery
title_full_unstemmed AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery
title_short AMTDB: A comprehensive database of autophagic modulators for anti-tumor drug discovery
title_sort amtdb: a comprehensive database of autophagic modulators for anti-tumor drug discovery
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395961/
https://www.ncbi.nlm.nih.gov/pubmed/36016573
http://dx.doi.org/10.3389/fphar.2022.956501
work_keys_str_mv AT fujiahui amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery
AT wulifeng amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery
AT hugaoyong amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery
AT shiqiqi amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery
AT wangruodi amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery
AT zhulingjuan amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery
AT yuhaiyang amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery
AT fuleilei amtdbacomprehensivedatabaseofautophagicmodulatorsforantitumordrugdiscovery